Skip to Main content Skip to Navigation
Journal articles

In vitro activity of ceftolozane-tazobactam against Enterobacter cloacae complex clinical isolates with different β-lactam resistance phenotypes

Abstract : The study evaluated the activity of ceftolozane-tazobactam (C/T) against 94 unique clinical isolates of complex (ECC). No difference was observed according to the ECC cluster. The activity greatly varied depending on the β-lactamase-producing profile: 100%, 67%, and 19% of wild-type, extended-spectrum β-lactamase (ESBL)-producing, and AmpC-overproducing strains, respectively, were susceptible to C/T. The use of C/T could be of interest for the treatment of some infections caused by ESBL-producing AmpC-nonoverexpressing ECC isolates.
Complete list of metadatas

Cited literature [21 references]  Display  Hide  Download

https://hal-univ-rennes1.archives-ouvertes.fr/hal-02313665
Contributor : Laurent Jonchère <>
Submitted on : Thursday, September 20, 2018 - 2:42:39 PM
Last modification on : Friday, May 29, 2020 - 2:50:04 PM

File

Robin - In vitro activity of c...
Files produced by the author(s)

Identifiers

Citation

Frédéric Robin, Michel Auzou, Richard Bonnet, Romain Lebreuilly, Christophe Isnard, et al.. In vitro activity of ceftolozane-tazobactam against Enterobacter cloacae complex clinical isolates with different β-lactam resistance phenotypes. Antimicrobial Agents and Chemotherapy, American Society for Microbiology, 2018, 62 (9), pp.e00675-18. ⟨10.1128/AAC.00675-18⟩. ⟨hal-02313665v2⟩

Share

Metrics

Record views

328

Files downloads

489